Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.


Skip to main content

You are invited to be a part of the distinctive future of Diabetes

The First Diabetes Innovation Summit for Healthcare Professionals in Central & Eastern Europe, Middle East & Africa

diabetes summit location icon


The event will take place in Hyatt Regency İstanbul - Ataköy. One of the largest metropols in the world, İstanbul is a strategical intersection point for almost everything. This distinctive city is one of the best options to host distinctive people at a special event.

diabetes summit hotel photos

Why Distinct?

We are the global healthcare technology leader, with more than 90,000 people across 150 countries. We innovate solutions that treat more than 70 health conditions, from Parkinson’s to diabetes. And while our healthcare technologies transform the lives of two people every second, every hour, of every day, expect more from us. We keep expanding our impact far beyond. In everything we do, we are engineering the extraordinary.

The rich history of diabetes within Medtronic is a distinctive story itself. This event will host the most distinctive healthcare professionals with the most innovative content. As this is the first Diabetes Innovation Summit organized by Medtronic, we are already thrilled to be sharing knowledge and expanding the opportunities about the future of diabetes. This extraordinary event needed an extraordinary name to tell its story.

Extraordinary Evolution in Medtronic Diabetes Technology

A word of welcome from the
Faculty of speakers

Get to know our Faculty of speakers

DISTINCT experts who will share their knowledge during the first
Diabetes Innovation Summit

     Click on the names to read their biography
innovation summit speakers

Tadej Battelino 

Ljubljana, Slovenia 

Consultant and Head of
Department of Pediatric and
Adolescent Endocrinology,
UMC Ljubljana
Head, Chair of Pediatrics, and
Professor of Paediatrics at
Faculty of Medicine,
University of Ljubljana 

innovation summit speakers

Goran Petrovski

Doha, Qatar

Senior Attending Physician at
Sidra Medicine, Doha, Qatar

innovation summit speakers

Johan Jendle

Örebro, Sweden

Chair Professor in Medicine at the
Institute of Medical Sciences and
Director of the Diabetes,
Endocrinology and Metabolism
Research Centre at the
University Hospital of Örebro,

innovation summit speakers

Robert Vigersky

Washington, DC, USA

Chief Medical Officer,
Global Medical and
Clinical Affairs,
Medtronic Diabetes
Past-President, Endocrine Society
Professor of Medicine,
Uniformed Services
University of the Health Sciences

innovation summit speakers

Damla Gökşen

İzmir, Türkiye 

Professor of Pediatrics
in Pediatric Endocrinology
and Diabetes Department
at Ege University Faculty
of Medicine, İzmir, Türkiye

innovation summit speakers

Ohad Cohen

Tolochenaz, Switzerland

Sr. Medical Affairs Director,
Medtronic Diabetes 

innovation summit speakers

Beatrix Sármán

Budapest, Hungary  

Associate professor at
Semmelweis University,
Faculty of Medicine.
Internal medicine and
Hematology Clinic,
Endocrin and Metabolism
Department, Budapest, Hungary

innovation summit speakers

Mohammed Alharbi

Riyadh, Kingdom of  Saudi Arabia 

Consultant Pediatric Endocrinologist
at Seha Virtual Hospital and
King Salman Hospital - Hail region, Kingdom of Saudi Arabia

innovation summit speakers

Nancy Elbarbary

Cairo, Egypt

Professor of Pediatric diabetes, Department of Pediatrics,
Faculty of medicine,
Ain shams University,
Cairo, Egypt

innovation summit speakers

Adolescent with Type 1 Diabetes

innovation summit speakers

Madison Smith 

San Diego, CA

Sr. Clinical R&D
Product Manager,

innovation summit speakers

Dania Choucair

Dubai, UAE

Clinical Research &
Medical Science
Director Medical Education
Learning & Innovation,
Medtronic, CEMA 

innovation summit speakers

Simona de Portu

Tolochenaz, Switzerland

Health Economics, Reimbursement and
GA Director,
Medtronic, EMEA

innovation summit speakers

Natalie Garcia Heil

Madrid, Spain

Patient Onboarding Programme Manager, Medtronic Diabetes, EMEA 

innovation summit speakers

Attila Detary

Brno, Czech Republic

HCP T&E Leader,
Medtronic Diabetes,

innovation summit speakers

Jot Singh    

Dubai, UAE

Principal Market Development
Specialist & NBMD Lead,
Medtronic Diabetes, EMEA

innovation summit speakers

Alessandro Muselli

Tolochenaz, Switzerland

Program and Technology Director,
Medtronic Diabetes, EMEA

agenda cover for diabetes summit

Download the detailed agenda

We know that in diabetes every minute counts. That’s why we designed a distinctive program to contribute to the efficiency of innovative learning.

Technology that transforms Lives

minimed image diabetes summit

MiniMed™ 780G system

Automated to help more patients reach glycaemic targets with less effort1,2,3,4 and no fingerpricks.*

  • Helps patients to reach time in range and HBA1C goals1,3,4,5
  • Automated to help more patients reach glycaemic targets with less effort1,2,3,4
  • Remote follow-ups and automatic uploads of patient data.**
infusion product image for diabetes summit

Medtronic Infusion sets and Reservoir 
for Insulin Pumps

Designed for everybody and every lifestyle.

  • Medtronic’s wide range of infusion sets aims to provide patients with the possibility to select the right infusion set for their comfort and safety. This selection should be based on your lifestyle, age, body type, preferences and clinical recommendations.
  • Medtronic Reservoirs are also available in 1.8 ml and 3.0 ml sizes in order to meet daily insulin needs.
carelink on screens image


Personalised patient outcomes.

  • Designed to take information from Medtronic insulin pumps, Continuous Glucose Monitoring (CGM) devices and Blood Glucose (BG) meters, CareLink™ System provides insightful reports, allowing you to spend more time on helping your patients manage their diabetes.
  • The portfolio of CareLink™ reports can identify trends, track daily activities and help you identify patterns and behaviour which may be affecting a patients diabetes management.
  • With CareLink™ System, you have: exclusive access to patients insight reports, access to reports via web browsers on PC, Mac or iPad tablets and online access, whenever and wherever you like.

Get to know Medtronic Diabetes therapies

mdi image diabetes summit

Smart MDI system

The Smart MDI systems combines the power of real time CGM with predictive glucose alerts and personalised insulin dosing to help your patients stay ahead of their glucose levels and take the right dose at the right time.6,7

  • Predict Highs and lows up to 60 minutes in advance6,7
  • Makes dosing easier for patients with a built-in insulin dose calculator
  • Automatically records both glucose levels and administered insulin with no fingerprick
  • The Smart MDI system can help patients to take the right dose at the right time
iport image for diabetes summit

i-Port Advance™

Let’s reduce the anxiety of injections together.8

  • i-Port Advance is a subcutaneous injection port enabling the user to administer multiple daily injections.
  • It can be worn for up to 72 hours thus may reduce the number of skin punctures related to administration from an average of 4-6 per day to just one every 3 days. i-Port Advance is for patients who want to reduce the intrusion of injections on daily life.

Tadej Battelino 

Professor Tadej Battelino completed his medical degree at the University of Ljubljana in 1990. He completed a PhD focusing on glucose metabolism in neonatal endotoxic shock in 1996. He completed his clinical fellowship at Loyola University of Chicago, USA, and his postdoctoral fellowship at INSERM, Paris, France.

Professor Battelino is currently Consultant and Head of Department of Pediatric and Adolescent Endocrinology, UMC Ljubljana, Head, Chair of Pediatrics, and Professor of Paediatrics at Faculty of Medicine, University of Ljubljana. He is PI on several publicly funded research projects in the field of diabetes, endocrinology and metabolism, and was awarded the Slovene national award for research in 2014, Gold medal for research at the University of Ljubljana in 2017, the ISPAD Achievement Award in 2020, and the Presidential Medal from Children with Diabetes society in 2022. Professor Battelino serves on the editorial boards for the journals Diabetes Care, Journal of Pediatric Endocrinology and Metabolism, Acta Diabetologica, and was Editor for the European Journal of Endocrinology from 2009 to 2015. He has authored or co-authored over 327 papers in international peer-reviewed journals and participated chapters to several international books. He has a cumulative h index of 60. 

Professor Battelino is a member of numerous professional associations including the American Diabetes Association (ADA), European Society for Paediatric Endocrinology (ESPE) and the International Society for Pediatric and Adolescent Diabetes (ISPAD), for which he served as President for the 35th Annual Congress. He served on the European Association for the Study of Diabetes (EASD) council and is co-organizer of sixteen annual meetings of the Advanced Technologies and Treatment of Diabetes - ATTD. He is elected Honorary member of the Italian Society for Pediatric Endocrinology and Diabetology (SIEDP) and the Hellenic Society of Pediatric and Adolescent Endocrinology (EEPEE).  Professor Battelino is a member of the Slovenian Medical Academy, Slovenian Academy of Sciences and Arts (SAZU),  and the European Academy of Sciences and Arts.


Shadin Mohammed

diabetes summit shadin child cv


1. Carlson AL, et al. Poster # 97 at the 80th International Conference of the American Diabetes Association, June 2020, Chicago/Virtual.
2. Medtronic data on file: Pivotal Trial (Age 14-75). N=157. 16 US sites; 2020.
3. Battelino T, et al. Diabetes Care 2019; 42(8): 1593-1603.
4. ADA Guidelines of A1C<7.0 –
5. Bosi E, et al. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemiaprone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial. Lancet Diabetes Endocrinol 2019;7: 462–72.
6. Abraham SB, et al. Improved Real-World Glycemic Control With Continuous Glucose Monitoring System Predictive Alerts. Journal of Diabetes Science and Technology 2021; 15(1):91–97
7. Smith M, et al, E5 , SIPs Improve Time Below Range in MDI Therapy, AMCP Congress 2020
8. Riley D, Raup G. Impact of a subcutaneous injection device on improving patient care. Nurs Manage. 2010;41(6):49-54
* A blood glucose (BG) reading is needed when entering SmartGuard™ feature. If glucose alerts and CGM readings do not match your symptoms, use a BG meter to make diabetes treatment decisions. Refer to System User Guide - SmartGuard™ feature. Some user interaction required.
** Refer to MiniMed™ Mobile app User Guide
† Some user interaction required.
‡ If CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. Refer to System User Guide
¶ Do not inject more than 75 times through a single device. This information does not substitute the Instructions for Use/User Guide. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for use.

diabetes summit graphic element